Sign in to continue:

Friday, April 3rd, 2026

Day: April 1, 2026

Aptose Biosciences 2025 Annual Report: Tuspetinib Clinical Development and Key Findings in AML Therapy

Detailed Investor Article: Aptose Biosciences 2025 Annual Re...

Streamex Corp. 2025 Annual Report: Nasdaq-Listed Electromedical Company Financial and Corporate Overview

Streamex Corp. 2025 Annual Report – Key Insights for Investo...